367 related articles for article (PubMed ID: 33656228)
21. Exploring the Phototoxicity of Hypoxic Active Iridium(III)-Based Sensitizers in 3D Tumor Spheroids.
Bevernaegie R; Doix B; Bastien E; Diman A; Decottignies A; Feron O; Elias B
J Am Chem Soc; 2019 Nov; 141(46):18486-18491. PubMed ID: 31644286
[TBL] [Abstract][Full Text] [Related]
22. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo.
He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561
[TBL] [Abstract][Full Text] [Related]
23. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes.
Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ
J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887
[TBL] [Abstract][Full Text] [Related]
24. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
[TBL] [Abstract][Full Text] [Related]
25. Cyclometalated Iridium(III) Complexes as Mitochondria-targeting Photosensitizers against Cisplatin-resistant Cells.
Xiong K; Zhou Y; Lin X; Kou J; Lin M; Guan R; Chen Y; Ji L; Chao H
Photochem Photobiol; 2022 Jan; 98(1):85-91. PubMed ID: 33617666
[TBL] [Abstract][Full Text] [Related]
26. Tracking mitochondrial dynamics during apoptosis with phosphorescent fluorinated iridium(iii) complexes.
Zhang C; Qiu K; Liu C; Huang H; Rees TW; Ji L; Zhang Q; Chao H
Dalton Trans; 2018 Oct; 47(37):12907-12913. PubMed ID: 30117504
[TBL] [Abstract][Full Text] [Related]
27. Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target.
Bevernaegie R; Marcélis L; Laramée-Milette B; De Winter J; Robeyns K; Gerbaux P; Hanan GS; Elias B
Inorg Chem; 2018 Feb; 57(3):1356-1367. PubMed ID: 29336560
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
[TBL] [Abstract][Full Text] [Related]
29. Enhancing the tumor cell selectivity of a rhodamine-decorated iridium(III) complex by conjugating with indomethacin for COX-2 targeted photodynamic therapy.
Liu C; Xiang J; Xiang C; Li H
Bioorg Chem; 2021 Sep; 114():105142. PubMed ID: 34243072
[TBL] [Abstract][Full Text] [Related]
30. X-ray tomography of cryopreserved human prostate cancer cells: mitochondrial targeting by an organoiridium photosensitiser.
Bolitho EM; Sanchez-Cano C; Huang H; Hands-Portman I; Spink M; Quinn PD; Harkiolaki M; Sadler PJ
J Biol Inorg Chem; 2020 Mar; 25(2):295-303. PubMed ID: 32124100
[TBL] [Abstract][Full Text] [Related]
31. Water-soluble cyclometalated Ir(III) complexes as carrier-free and pure nanoparticle photosensitizers for photodynamic therapy and cell imaging.
Tong X; Zhang L; Li L; Li Y; Yang Z; Zhu D; Xie Z
Dalton Trans; 2020 Aug; 49(33):11493-11497. PubMed ID: 32789382
[TBL] [Abstract][Full Text] [Related]
32. Application of Mono and Trinuclear Cyclometalated Iridium (III) Complexes in Differential Bacterial Imaging and Antimicrobial Photodynamic Therapy.
Das B; Biswas P; Mallick AI; Gupta P
Chemistry; 2024 Jun; 30(36):e202400646. PubMed ID: 38652686
[TBL] [Abstract][Full Text] [Related]
33. Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.
Laws K; Eskandari A; Lu C; Suntharalingam K
Chemistry; 2018 Oct; 24(57):15205-15210. PubMed ID: 30052298
[TBL] [Abstract][Full Text] [Related]
34. Ligand Dictated Photosensitization of Iridium(III) Dithiocarbamate Complexes for Photodynamic Therapy.
Negi M; Dixit T; Venkatesh V
Inorg Chem; 2023 Dec; 62(49):20080-20095. PubMed ID: 37994001
[TBL] [Abstract][Full Text] [Related]
35. Phosphorescent rhenium(I) complexes conjugated with artesunate: Mitochondrial targeting and apoptosis-ferroptosis dual induction.
Ye RR; Chen BC; Lu JJ; Ma XR; Li RT
J Inorg Biochem; 2021 Oct; 223():111537. PubMed ID: 34273716
[TBL] [Abstract][Full Text] [Related]
36. Chiral Iridium-Based TLD-1433 Analogues: Exploration of Enantiomer-Dependent Behavior in Photodynamic Cancer Therapy.
Wang W; Wang L; Zhang Y; Shi Y; Zhang R; Chen L; Shi Z; Yuan S; Li X; He C; Li X
Inorg Chem; 2024 Apr; 63(17):7792-7798. PubMed ID: 38619892
[TBL] [Abstract][Full Text] [Related]
37. Quantitative tracking of endoplasmic reticulum viscosity during ferroptosis by an iridium complex
Hao L; Zhong YM; Tan CP; Mao ZW
Chem Commun (Camb); 2021 May; 57(41):5040-5042. PubMed ID: 33881416
[TBL] [Abstract][Full Text] [Related]
38. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
[TBL] [Abstract][Full Text] [Related]
39. Bithiophene-Functionalized Infrared Two-Photon Absorption Metal Complexes as Single-Molecule Platforms for Synergistic Photodynamic, Photothermal, and Chemotherapy.
Li XL; Wang MF; Zeng LZ; Li GK; Zhao RY; Liu FD; Li Y; Yan YF; Liu Q; Li Z; Zhang H; Ren X; Gao F
Angew Chem Int Ed Engl; 2024 Jul; 63(27):e202402028. PubMed ID: 38656658
[TBL] [Abstract][Full Text] [Related]
40. Recent Advances in the Design of Targeted Iridium(III) Photosensitizers for Photodynamic Therapy.
Huang H; Banerjee S; Sadler PJ
Chembiochem; 2018 Aug; 19(15):1574-1589. PubMed ID: 30019476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
